ENTRY       D09635                      Drug
NAME        Linifanib (USAN/INN)
FORMULA     C21H18FN5O
EXACT_MASS  375.1495
MOL_WEIGHT  375.3989
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
EFFICACY    Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor
TARGET      VEGFR1 (FLT1) [HSA:2321] [KO:K05096]
            VEGFR2 (KDR) [HSA:3791] [KO:K05098]
            VEGFR3 (FLT4) [HSA:2324] [KO:K05097]
            PDGFR [HSA:5156 5159] [KO:K04363 K05089]
            CSF1R (FMS, CD115) [HSA:1436] [KO:K05090]
  PATHWAY   hsa04010(1435+2321+2324+3791+5156+5159)  MAPK signaling pathway
            hsa04060(1435)  Cytokine-cytokine receptor interaction
            hsa04151(1435+2321+2324+3791+5156+5159)  PI3K-Akt signaling pathway
            hsa04370(3791)  VEGF signaling pathway
            hsa05200(2324+5156+5159)  Pathways in cancer
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                D09635  Linifanib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                PDGFR
                 D09635  Linifanib (USAN/INN)
               VEGFR family
                VEGFR1 (FLT1)
                 D09635  Linifanib (USAN/INN)
                VEGFR2 (KDR)
                 D09635  Linifanib (USAN/INN)
                VEGFR3 (FLT4)
                 D09635  Linifanib (USAN/INN)
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF1R (FMS, CD115)
                 D09635  Linifanib (USAN/INN)
DBLINKS     CAS: 796967-16-3
            PubChem: 124490375
            ChEBI: 91435
            LigandBox: D09635
ATOM        28
            1   C8x C    13.5100  -21.4200
            2   C8y C    13.5100  -22.8200
            3   C8x C    14.7224  -23.5200
            4   C8x C    15.9349  -22.8200
            5   C8y C    15.9349  -21.4200
            6   C8x C    14.7224  -20.7200
            7   N1b N    17.1660  -20.7090
            8   C5a C    18.3712  -21.4047
            9   N1b N    19.5535  -20.7219
            10  O5a O    18.3716  -22.8196
            11  C8y C    20.7475  -21.4112
            12  C8y C    20.7476  -22.8197
            13  C8x C    21.9601  -23.5196
            14  C8x C    23.1725  -22.8195
            15  C8y C    23.1723  -21.4109
            16  C8x C    21.9598  -20.7111
            17  X   F    19.5146  -23.5321
            18  C1a C    24.3790  -20.7141
            19  C8y C    12.2976  -23.5200
            20  C8y C    11.1021  -22.8296
            21  C8y C     9.8896  -23.5295
            22  C8x C     9.8894  -24.9295
            23  C8x C    11.0849  -25.6199
            24  C8x C    12.2974  -24.9200
            25  C8y C    10.8111  -21.4602
            26  N5x N     9.4188  -21.3137
            27  N4x N     8.8493  -22.5926
            28  N1a N    11.7192  -20.4518
BOND        31
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    8  10 2
            11    9  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   11  16 1
            18   12  17 1
            19   15  18 1
            20    2  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   19  24 1
            27   20  25 1
            28   25  26 2
            29   26  27 1
            30   21  27 1
            31   25  28 1
///
